e-learning
resources
Vienna 2009
Monday, 14.09.2009
Trends in bronchoscopy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Histology, performance status and lymphopenia are factors of survival in patients undergoing thoracoscopy for malignant pleural effusion
S. Anevlavis, I. Sotiriou, G. Kouliatsis, D. Bouros, M. Froudarakis (Alexandroupolis, Greece)
Source:
Annual Congress 2009 - Trends in bronchoscopy
Session:
Trends in bronchoscopy
Session type:
E-Communication Session
Number:
2913
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Anevlavis, I. Sotiriou, G. Kouliatsis, D. Bouros, M. Froudarakis (Alexandroupolis, Greece). Histology, performance status and lymphopenia are factors of survival in patients undergoing thoracoscopy for malignant pleural effusion. Eur Respir J 2009; 34: Suppl. 53, 2913
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Lipoid pneumonia in infants: treatment with multiple bronchoalveolar lavages
Related content which might interest you:
Prognostic factors in patients with malignant pleural effusion undergoing thoracoscopy
Source: Annual Congress 2011 - From outside to inside: access to the pleura
Year: 2011
Predictors of survival in patients with recurrent malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011
Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021
Karnofsky score, pH and degree of pleural involvement as prognostic factors for survival in patients with malignant pleural effusions
Source: Annual Congress 2012 - Chest wall, thoracic trauma and complications in thoracic surgery
Year: 2012
CD8+ lymphocyte subpopulations in pleural fluid are associated with longer survival in patients with malignant pleural effusion (MPE) submitted to thoracoscopic talc pleurodesis
Source: Eur Respir J 2002; 20: Suppl. 38, 70s
Year: 2002
The role of surgery in cytologically positive pleural effusion in NSCLC
Source: Annual Congress 2003 - Lung cancer surgery: prognostic factors
Year: 2003
The role of diagnostic thoracoscopy in patients with lung cancer and pleural effusion
Source: Eur Respir J 2003; 22: Suppl. 45, 542s
Year: 2003
Predictors of successful pleurodesis for patients with malignant pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 493s
Year: 2004
Impact of sarcopenia in long-term symptoms in patients with malignant pleural effusion.
Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Year: 2021
Prognostic factors associated to survival in patients with malignant pleural effusion (MPE) undergoing talc poudrage pleurodesis (TPP)
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Outcomes of cytology positive malignant pleural effusions; do certain malignancies predispose patients to trapped lung?
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019
Systemic treatment of malignant pleural effusion
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005
Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma?
Source: Eur Respir J 2003; 22: Suppl. 45, 29s
Year: 2003
Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002
Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005
Medical thoracoscopy for diagnosis of pleural effusion in cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 528s
Year: 2004
Pleurodesis after intrapleural catheter insertion is an independent factor for overall survival in patients with malignant pleural effusions
Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours
Year: 2009
Diagnostic thoracoscopy in patients with lung cancer and pleural effusion
Source: Annual Congress 2007 - Pleural techniques and diagnosis of peripheral lung nodules
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept